Thomson Reuters, a major vendor of business intelligence services and technology spanning multiple industries, intends to divest its health care operations.

The New York-based company will use the proceeds to invest in its core markets including legal, tax and accounting, science and intellectual property, financial services, and media, according to a statement from CEO Thomas Glocer.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access